Analytica Osake

Analytica EBIT per osake

Delisted

EBIT per osake yhtiöstä Analytica (ALT.AX) 7.8.2026 päivämäärällä on −0,00 AUD. Edellisenä vuonna EBIT per osake oli −0,00 AUD — muutos 18,09 % (matalampi).

EBIT per osake

−0,00AUD

YoY

18,09%

Viimeksi päivitetty:

EBIT per osake yhtiöstä Analytica on 2026 −0,00 AUD. EBIT per osake yhtiöstä Analytica oli 2025 −0,00 AUD. Se laskee 18,09% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Analytica Osakeanalyysi

Mitä Analytica tekee? Analytica Ltd is a British company that was founded in 1970 by Dr. John Smith. Originally, it specialized in the development of analysis instruments for the chemistry and life sciences, particularly liquid chromatography. Over the years, the company expanded its offerings and now provides a wide range of products and services. Analytica Ltd has become a global company with a presence in over 130 countries. It operates in various business areas, including analytical chemistry, bioanalysis, environmental and food analysis, and clinical diagnostics. The company offers customers a wide range of products, such as chromatography systems, mass spectrometers, specialized analysis devices, and consumables. It has also specialized in the development and manufacturing of medical devices, including diagnostic tools for conditions such as diabetes, cholesterol, and other metabolic diseases. Analytica Ltd incorporates innovative technologies like miniaturization and nanotechnology into its products. In addition to product sales, Analytica Ltd provides tailored services. The company has highly qualified experts who assist customers with method development, process optimization, and data interpretation. It also conducts research and development programs to continuously develop new products and technologies. Analytica Ltd maintains numerous collaborations and partnerships with other companies and organizations. For example, it works closely with research institutions and universities to develop new technologies and products. The company also connects with other companies in the health and analytical industries to share innovations and best practices. Overall, Analytica Ltd is a leading provider of analysis solutions for the pharmaceutical, biotech, chemical, and food industries, as well as research institutions and clinical laboratories. The company is continuously working to further develop its products and services to meet the needs of its customers and address the ever-changing challenges of the industry. Analytica on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Analytica osakkeesta

Yhtiön Analytica EBIT per osake on −0,00 AUD vuonna 2026.

EBIT per osake yhtiöstä Analytica muuttui arvosta −0,00 AUD arvoon −0,00 AUD, mikä edustaa 18,09 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBIT per osake Analytica:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBIT per osake mittaa operatiivisen voiton, joka on kohdistettu kullekin ulkona olevalle osakkeelle.

Access this data via the Eulerpool API

Tuloslaskelma — Analytica

Kaikki tunnusluvut — Analytica